Evidence map›Paper›PMID 39614327›Full record

ArticleMalaria journal2024

Correction: Chemoprevention of malaria with long-acting oral and injectable drugs: an updated target product profile.

Myriam El Gaaloul, Andre Marie Tchouatieu, Kassoum Kayentao, Brice Campo, Benedicte Buffet, Hanu Ramachandruni, Jean Louis Ndiaye, Timothy N C Wells, Celine Audibert, Jane Achan and 3 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Malaria journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Myriam El GaaloulMMV Medicines for Malaria Venture, Route de Pré‑Bois 20, Post Box 1826, 1215, Geneva 15, Switzerland. elgaaloulm@mmv.org.
Andre Marie TchouatieuMMV Medicines for Malaria Venture, Route de Pré‑Bois 20, Post Box 1826, 1215, Geneva 15, Switzerland. tchouatieua@mmv.org.
Kassoum KayentaoMalaria Research and Training Center, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Brice CampoMMV Medicines for Malaria Venture, Route de Pré‑Bois 20, Post Box 1826, 1215, Geneva 15, Switzerland.
Benedicte BuffetMMV Medicines for Malaria Venture, Route de Pré‑Bois 20, Post Box 1826, 1215, Geneva 15, Switzerland.
Hanu RamachandruniMMV Medicines for Malaria Venture, Route de Pré‑Bois 20, Post Box 1826, 1215, Geneva 15, Switzerland.
Jean Louis NdiayeUniversity Iba Der Thiam of Thiès, Thiès, Senegal.
Timothy N C WellsMMV Medicines for Malaria Venture, Route de Pré‑Bois 20, Post Box 1826, 1215, Geneva 15, Switzerland.
Celine AudibertMMV Medicines for Malaria Venture, Route de Pré‑Bois 20, Post Box 1826, 1215, Geneva 15, Switzerland.
Jane AchanMalaria Consortium, London, UK.
Cristina DoniniMMV Medicines for Malaria Venture, Route de Pré‑Bois 20, Post Box 1826, 1215, Geneva 15, Switzerland.
Hellen C BarsosioKenya Medical Research Institute, Centre for Global Health Research, Kisumu, Kenya.
Halidou TintoClinical Research Unit of Nanoro, Institut de Recherche en Sciences de la Santé, Nanoro, Burkina Faso.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39614327
PMCPMC11605851

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.